GlassScriptPhysician profile
Jonathan Andrew Haas
NPI 1023058989
$51,822.22
in general payments reported to CMS, 2019-2025
7 companies · $2,159 in 2025
The $2,159 reported for 2025 was more than what 90% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,142 · 2020: $72.21 · 2021: $3,144 · 2022: $25K · 2023: $13K · 2024: $594 · 2025: $2,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $6,435 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Consulting Fee: $2,050 · Food and Beverage: $1,358 · Travel and Lodging: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $6,434.65 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Consulting Fee | $2,050.00 |
| Food and Beverage | $1,357.74 |
| Travel and Lodging | $832.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accuray Incorporated | $49,640.01 | 2019-2025 | Cyberknife System |
| Ge Healthcare | $1,617.00 | 2021 | |
| Teleflex LLC | $232.09 | 2024 | |
| Boston Scientific Corporation | $198.43 | 2021-2023 | Spaceoar System |
| Janssen Biotech, INC. | $87.37 | 2019 | |
| Blue Earth Diagnostics | $24.41 | 2025 | Posluma |
| Palette Life Sciences, INC. | $22.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.